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Abstract
Background: Radiotherapy is widely used to treat cancer. While rapidly dividing cancer cells are naturally considered the
main target of radiotherapy, emerging evidence indicates that radiotherapy also affects endothelial cell functions, and
possibly also their angiogenic capacity. In spite of its clinical relevance, such putative anti-angiogenic effect of radiotherapy
has not been thoroughly characterized. We have investigated the effect of ionizing radiation on angiogenesis using in vivo,
ex vivo and in vitro experimental models in combination with genetic and pharmacological interventions.
Principal Findings: Here we show that high doses ionizing radiation locally suppressed VEGF- and FGF-2-induced Matrigel
plug angiogenesis in mice in vivo and prevented endothelial cell sprouting from mouse aortic rings following in vivo or ex
vivo irradiation. Quiescent human endothelial cells exposed to ionizing radiation in vitro resisted apoptosis, demonstrated
reduced sprouting, migration and proliferation capacities, showed enhanced adhesion to matrix proteins, and underwent
premature senescence. Irradiation induced the expression of P53 and P21 proteins in endothelial cells, but p53 or p21
deficiency and P21 silencing did not prevent radiation-induced inhibition of sprouting or proliferation. Radiation induced
Smad-2 phosphorylation in skin in vivo and in endothelial cells in vitro. Inhibition of the TGF-b type I receptor ALK5 rescued
deficient endothelial cell sprouting and migration but not proliferation in vitro and restored defective Matrigel plug
angiogenesis in irradiated mice in vivo. ALK5 inhibition, however, did not rescue deficient proliferation. Notch signaling,
known to hinder angiogenesis, was activated by radiation but its inhibition, alone or in combination with ALK5 inhibition,
did not rescue suppressed proliferation.
Conclusions: These results demonstrate that irradiation of quiescent endothelial cells suppresses subsequent angiogenesis
and that ALK5 is a critical mediator of this suppression. These results extend our understanding of radiotherapy-induced
endothelial dysfunctions, relevant to both therapeutic and unwanted effects of radiotherapy.
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Introduction
Radiotherapy is a well-established therapeutic modality in
clinical oncology. It is applied to over half of all cancer patients
during the course of their disease, as curative-intent, adjuvant or
palliative treatment [1]. The main mechanism by which
radiotherapy is thought to exert its therapeutic anti-cancer effects
is through the induction of double-strand DNA breaks. The extent
of the DNA damage in cancer cells together with their proliferative
and the genetic conditions, will determine whether irradiated
cancer cells will survive, will undergo senescence or will die by
apoptosis or mitotic catastrophe [2]. Radiotherapy also affects
non-tumoral cells present in the tumor microenvironment and
surrounding tissues, including endothelial cells [3]. Ionizing
radiation was reported to induce apoptosis of endothelial cells of
the tumor vasculature, resulting in tumor vessel disruption and
delayed tumor growth [4]. Moreover, radiotherapy can affect
quiescent endothelium in healthy tissues. Microvessels (capillaries
and sinusoids) are most sensitive, displaying damages of endothe-
lial cells, resulting in teleangectasia, capillary rupture and
thrombosis. Medium-size vessels show neointimal proliferation,
fibrinoid necrosis, thrombosis and acute arteritis. Large vessels are
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less affected, although arterial thrombosis and atheromatosis were
reported [5]. These radiation-induced vascular modifications are
associated with increased risk of serious complications in
radiotherapy-treated patients, including arterial occlusions, heart
attacks and stroke [6,7,8]. Furthermore, it has been supposed that
exposure of quiescent vasculature to ionizing radiation might
inhibit a subsequent angiogenic response. Endothelial dysfunctions
and impaired angiogenesis are thought to contribute to late tissue
damages observed after radiotherapy including perturbed wound
healing, tissue fibrosis and organ dysfunctions [9].
In spite of its clinical relevance, whether irradiation of quiescent
vasculature impinges on subsequent (de novo) angiogenesis and the
possible mechanisms involved have not been thoroughly investigated.
In this work we have addressed these questions through in vivo and in
vitro experiments in combination with genetic and pharmacological
interventions. Here we report that irradiation prevents vascular
growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) -
induced angiogenesis in vivo, and suppresses endothelial cell
proliferation, migration and sprouting in vitro. Radiation activates
the TGF-b type I receptor/activin receptor-like kinase-5 (ALK5)
pathway and pharmacological ALK5 inhibition prevents radiation-
induced suppression of endothelial cell migration and sprouting in
vitro, and impairment of angiogenesis in vivo. By demonstrating that
irradiation of quiescent vasculature inhibits subsequent angiogenic
responses and by providing a cellular and molecular mechanism,
these results broaden our understanding of radiation-induced
endothelial cell dysfunctions relevant to normal tissue homeostasis
and cancer biology.
Results
High-dose ionizing radiation inhibits VEGF and FGF-2-
induced angiogenesis in healthy skin
To test whether high doses of ionizing radiation might inhibit de
novo angiogenesis, we performed Matrigel plug angiogenesis assays
[10] in non-irradiated mice and in locally pre-irradiated mice
(single X-ray dose of 20 Gy at the site of plug implantation). This
dose corresponds to a biological cumulative dose of 50–60 Gy
(based on the linear-quadratic model depending on the chosen a/
b values) delivered to patients during fractionated radiotherapy,
and is therefore of clinical significance [11]. Tissue pre-irradiation
fully suppressed vascular endothelial growth factor (VEGF) - and
fibroblast growth factor-2 (FGF-2) - induced angiogenesis, as
determined by macroscopic examination and by measuring the
haemoglobin content of the recovered plugs (Figure 1a and 1b).
CD31 immunofluorescence staining of the Matrigel plugs
confirmed the absence of blood vessels ingrowths into plugs
implanted within the pre-irradiated tissue, compared to plugs
implanted in non-irradiated tissue (Figure 1c). Also, angiogenesis
occurred normally in Matrigel plugs implanted outside the pre-
irradiated area in the same mice, indicating that the effect is not
systemic but rather restricted to the irradiated tissue (Figure 1b,
FGF-2/IR/Outside).
These results demonstrate that radiation inhibits VEGF- and
FGF-2-induced de novo angiogenesis and that the effect is limited to
the irradiated tissue.
Ionizing radiation does not induce apoptosis in quiescent
endothelial cells
Next, we tested whether deficient angiogenesis observed in
Matrigel plugs was due to radiation-induced disruption of pre-
existing vessels in the irradiated area into which plugs were
implanted. First we determined the microvascular density (MVD)
in the skin 6 days after local irradiation (20 Gy, single dose) vs. no
irradiation. No significant differences in vascular morphology and
MVD were observed (Figure 2a). To directly assess whether
radiation might induce apoptosis in quiescent endothelial cells, we
performed in situ TUNEL assays and CD31 co-staining of skin
before and at various time points after irradiation. Up to 10 days
after irradiation there was no evidence for the appearance of
TUNEL-positive endothelial cells in the irradiated dermis
(Figure 2b). In contrast, we observed TUNEL-positive cells in
the epidermis and dermis 10 days after irradiation, consistent with
radiation-induced apoptosis of keratinocytes and fibroblasts
[12,13]. Moreover, we monitored the induction of apoptosis in
confluent HUVEC cultures by radiation (15 Gy) using AnnexinV
and 7AAD double staining. No significant loss of cells or increase
in the apoptotic fraction was observed in irradiated confluent
cultures maintained confluent or passaged four days after
irradiation (Figure 2c, and Figure S1a). Irradiation of proliferating
HUVEC (i.e. sub-confluent cultures) resulted in massive death
within four days after irradiation (Figure S1b).
From these results we conclude that local irradiation does not
disrupt quiescent dermal vessels in vivo and does not induce
apoptosis in quiescent dermal endothelial cells in vivo, nor in
confluent HUVEC in vitro.
Radiation of confluent HUVEC induces premature
senescence
HUVEC that were irradiated as confluent cultures and further
passaged (1:3 dilutions) remained sparse compared to non-
irradiated cultures, which reached confluence four days after
splitting (Figure 3a). This observation suggested that irradiation of
confluent endothelial cells prevented re-entry into the cell cycle
once cells were placed in proliferation-inducing conditions. We
therefore analyzed the effect of irradiation on cell cycle by
measuring Ki67 expression and 7AAD staining by multiparameter
flow cytometry [14]. Confluent, non-irradiated HUVEC were
approximately 40% in G0, 50% in G1 and less than 10% in G2/
M while confluent irradiated HUVEC were over 90% in G0 and
less than 10% in G1 and G2/M (Figure 3b). Cell cycle quiescence
and lack of apoptosis suggested the possibility that irradiation
induced endothelial cell senescence. To collect further evidence for
this we performed senescence-associated b-galactosidase staining
of confluent irradiated and non-irradiated HUVEC cultures. Sixty
percent of irradiated HUVEC were b-galactosidase positive 4 days
after irradiation compared to only 16% in control cultures. Of
note, irradiated HUVEC developed a large and flattened cell
shape with granular cytoplasm, another hallmark of senescent cells
(Figure 3c).
Based on these results we conclude that irradiation of confluent
endothelial cells prevents re-entry into the cell cycle and induces
premature senescence.
Ionizing radiation inhibits endothelial cell sprouting
Next we assessed whether irradiation had a direct impact on
endothelial cell sprouting using the ex vivo aortic ring endothelial
cell sprouting assay [15]. In a first experiment we exposed mice to
15 Gy, single dose, whole body irradiation and 5 days later we
removed the aorta to perform the assay. Irradiation strongly
suppressed VEGF-induced sprouting compared to non-irradiated
control (Figure 4a). We also treated mice with fractionated
radiation therapy to mimic the clinical situation in which patients
are treated with multiple low doses. Radiation was given as 3 Gy
single doses, five times every 2 days. Consistent with the single
dose treatment experiment, we observed a significant decrease in
endothelial cell sprouting also with fractionated therapy
(Figure 4b). In a second experimental setting we embedded non-
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Figure 1. Inhibition of Matrigel plug angiogenesis by skin pre-irradiation. (a) VEGF-induced Matrigel plug angiogenesis assay was
performed within non-irradiated or 20 Gy pre-irradiated areas on the back of distinct C57/BL6 mice. Bar = 0.5 cm. *P,0.05. (n = 7). (b) FGF-2 induced
Matrigel plug angiogenesis assay was performed within non-irradiated area either on the back of distinct Swiss nude mice (upper panels) or within
and outside a 20 Gy irradiated dorsal area on the same mouse (lower panes) (n = 7). Matrigel without growth factor was used as a negative control.
Angiogenesis was quantified by measuring haemoglobin concentration in the recovered Matrigel plugs. Bar = 0.5 cm. *P,0.0001. (c) Staining of CD31
positive endothelial cells (red) and DAPI (blue) was performed on frozen Matrigel sections. Bar = 60 mm. Matrigel implanted within the irradiated area
lacks endothelial cells (n = 10). NIR: non-irradiated, IR: irradiated.
doi:10.1371/journal.pone.0011084.g001
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Figure 2. Quiescent endothelial cells in vivo and in vitro are resistant to radiation-induced apoptosis. (a) Sections of non-irradiated skin and
of 20 Gy irradiated skin 6 days after irradiation were stained by immunohistochemistry for CD31 (brown). Bar = 60 mm. The graph on the right represents
the microvessel density (MVD) of the skin at day 1, 3 and 6 after irradiation and non-irradiated controls. For quantification 5 regions were selected from
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irradiated aortic rings in collagen gels and irradiated them two
days later (8 Gy, single dose), a time at which sprouting had
already started. Irradiation effectively suppressed further sprout-
ing, without causing regression of already formed sprouts
(Figure 4c). In a third experimental model we performed an
endothelial cell spheroid sprouting assays using purified HUVEC
[16] to exclude that cells other then endothelial cells present in the
vascular wall of aortic rings, in particular, fibroblasts, could
potentially influence endothelial cell sprouting in response to
radiation through paracrine effects [17]. Gel-embedded HUVEC
spheroids were irradiated (8 Gy, single dose) and sprouting
induced by VEGF. Also in this model radiation significantly
suppressed VEGF-induced HUVEC sprouting (Figure 5).
Taken together these experiments demonstrate that irradiation
effectively inhibits endothelial cell sprouting though a direct effect
on endothelial cells.
Ionizing radiation suppresses endothelial cell migration
Since endothelial cell migration is an essential event for
sprouting angiogenesis [18], we tested whether ionizing radiation
might inhibit endothelial cell migration. To this purpose we
compared the migratory capacity of irradiated (15 Gy, single
dose), vs. non-irradiated HUVEC in a scratch wound closure
assay. In non-irradiated cultures wound closure was nearly
completed after 10 hours, while in irradiated cultures the wound
remained largely open (Figure 6a). Single cell tracking revealed
that irradiated HUVEC migrated at reduced speed, resulting in a
decreased migration distance, compared to non-irradiated HU-
VEC (Figure 6b). Concomitantly, irradiated HUVEC displayed an
increased adhesion to collagen and fibronectin substrates, as tested
in a short-term adhesion assay (Figure 6c). Of interest, HUVEC
undergoing replicative senescence after 20 passages (expressing
senescence-associated b-galactosidase activity, data not shown)
also had a decreased migration comparable to that observed in
radiation-treated HUVEC (Figure S2).
Non-irradiated, migrating HUVEC at the woundmargin showed
a typical polarized phenotype with lamellipodia formation at the
leading front, decreased actin stress fibers, appearance of cortical
actin, accumulation of focal adhesions at the leading front (L) and at
the trailing edge (T) (Figure 6d). Confluent HUVEC distant from
the wound edge were not polarized, retained a cobble-stone-like
morphology, focal adhesions around the cell periphery and well-
formed actin stress fibers. Irradiated HUVEC at the wound edge
showed little signs of polarization, retained a well spread
morphology, focal adhesion distribution and F-actin stress fibers
comparable to confluent, non-migrating cells (Figure 6d).
These results demonstrate that irradiation of quiescent endo-
thelial cells effectively suppresses subsequent their migratory
capacities.
Radiation-induced activation of the P53-P21 pathway is
not critical for the inhibition of endothelial sprouting
Two pathways are known to induce cell cycle arrest and
senescence: the P16-Rb and P53-P21 pathways. Radiation is a
potent inducer of P53 activation in response to double-strand
DNA breaks [19]. Indeed, irradiation of confluent HUVEC
induced DNA breaks as demonstrated by phospho (P)-H2AX
nuclear staining, a hallmark of DNA double strand breaks [20]
(Figure 7a). Twenty-four hours after irradiation P-H2AX returned
to basal levels demonstrating effective DNA repair. Western
blotting for P53, P21 and P16 proteins revealed a rapid
enhancement of P53 protein followed by an increased in P21
levels, while P16 levels remained unchanged (Figure 7b). These
results suggested the possible involvement of P21 in radiation-
induced senescence and decreased sprouting, migration and
proliferation. To test this hypothesis, we silenced P21 expression
in HUVEC through lentivirus-mediated delivery of P21shRNA
(Figure 7c). Silencing of P21 with the most efficient P21shRNA
(shRNA3) partially rescued radiation-induced senescence
(Figure 7d) and, to a minor extent, the migration defect
(Figure 7e), but not the proliferation defect (Figure S3a).
To test for a role of P21 in radiation-induced inhibition of
sprouting, we performed aortic ring sprouting assays using rings
obtained from aorta of p21-null mice. Absence of p21 did not rescue
radiation-induced inhibition of sprouting (15 Gy) compared to non-
irradiated rings (Figure S3b). Consistent with this finding, aortic ring
sprouting assays performed using aorta from p53-null mice did not
rescue radiation-induced inhibition of sprouting (Figure S3c). We
also performed sprouting assays using aortic rings obtained from
p16Ink4A-/- mice. Lack of p16 did not rescue the angiogenic defect of
irradiated rings (data not shown), consistent with the absence of
induction of P16 protein in irradiated HUVEC.
Taken together these results demonstrate that the P53-P21
pathway is induced upon irradiation in endothelial cells but
appears not to be involved in suppressing endothelial sprouting,
under the tested experimental conditions.
Radiation activates the TGF-bRI/ALK5 pathway and ALK5
inhibition prevents radiation-induced suppression of
migration and sprouting
Endothelial cells express two different TGF-b type I receptors,
the activin receptor-like kinase (ALK) -1 and -5, which form
heterodimers with TGF-b type II subunit. ALK-1 and ALK-5 have
distinct activity profiles. ALK1 stimulates endothelial cell prolifer-
ation and migration via Smad1/5/8 transcription factors, whereas
ALK5 inhibits endothelial cell proliferation and migration via
Smad2/3 transcription factors [21]. Since TGF-b is induced by
radiation in vitro and in vivo including in the skin [22,23] and during
tumor treatment with radio- and chemotherapy [24], we tested
whether TGF-b signaling was activated in our model by monitoring
Smad-2 phosphorylation in skin and HUVEC in response to
ionizing radiation. Radiation induced a rapid increase in phospho-
Smad-2 with an early peak at 6 hours followed by sustained
phosphorylation (Figure 8a). Radiation also induced expression of
PAI-1 mRNA, an ALK5 target gene, which was inhibited by the
small molecular ALK5 inhibitor SB431542 (Figure 8b). We then
monitored the effect of radiation on TGF-b1, ALK5 and TGF-bRII
mRNA expression. TGF-b1 and ALK5 mRNA were expressed but
each slide (n= 5). There was no significant difference in the MVD of irradiated vs. non-irradiated skin. (b) Apoptosis detection in irradiated skin by TUNEL
assay. Frozen skin sections prepared before (t = 0), and 4 hours, 24 hours and 10 days after local radiation (20 Gy) were stained with TUNEL reaction
(green), anti-CD31 mAb (red) and DAPI (blue). Bars = x100: 60 mm, x200: 30 mm At 10 days after radiation, keratinocytes within the irradiated skin are
largely TUNEL positive, while endothelial cells are negative. The numbers above the images give the quantification of TUNEL positive cells within the
total cell population (blue) and CD31+ endothelial cells (red). No TUNEL+ endothelial cells were detected. (c) Detection of apoptosis in irradiated
confluent HUVEC cultures. Left panel: frequency of apoptotic cells 4 days after 15 Gy irradiation of confluent HUVEC. Right panel: frequency of apoptotic
cells in HUVEC cultures irradiated, split 4 days after radiation and cultured for another 4 days. There was no significant increase in apoptosis within
irradiated confluent HUVEC cultures. Apoptotic cells were detected by Annexin V/7AAD staining. NIR: non-irradiated, IR: irradiated.
doi:10.1371/journal.pone.0011084.g002
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not further induced by irradiation (Figure S4a and data not shown).
In contrast, TGF-bRII mRNA expression was strongly induced by
radiation with a biphasic profile (peak at 6 hours, over 20 fold
induction, and increase again at 96 hours, ,8 fold induction)
(Figure S4b). Since TGF-b inhibits endothelial cell proliferation and
migration through ALK5 [25], we tested the effect of the ALK5
inhibitor SB431542 on radiation-induced impairment of endothe-
lial cell migration and sprouting. SB431542 treatment effectively
prevented radiation-induced inhibition of migration of cultured
HUVEC (Figure 8c) and restored sprouting in irradiated aortic
rings (Figure 8d) and in irradiated HUVEC spheroids (Figure 8e) to
levels observed under non-irradiated conditions. SB431542 treat-
ment, however, did not rescue radiation-induced proliferation
impairment (Figure S5a). Also, combined P21 silencing and
SB431542 treatment did not prevent radiation-induced inhibition
of proliferation (data not shown).
Ionizing radiation was recently reported to activate the Notch
pathway in endothelial cells [26]. Since Notch signaling inhibits
endothelial proliferation [27], sprouting [28] and angiogenesis
[29], and TGF-b can activate Notch signaling [30] and cooperate
with Notch activation in inhibiting cell proliferation [31], we tested
whether the Notch pathway could be involved in impaired
proliferation observed in our model. Indeed irradiation activated
the Notch pathway, as demonstrated by the expression of the
Notch target genes Hey1, and its inhibition by the c-secretase
inhibition GSI (Figure S5b). SB431542 did not inhibit radiation-
induced Notch activation but it rather enhanced it (Figure S5b,
black bar). GSI treatment, alone or in combination with
SB431542 did not rescue radiation-induced suppression of
endothelial cell proliferation (Figure S5c).
Taken together these results indicate that TGF-b/ALK5
signaling mediates radiation-induced inhibition of migration and
sprouting, but not proliferation arrest, and exclude a contribution
of radiation-induced Notch activation in proliferation arrest.
ALK5 inhibition prevents radiation-induced inhibition of
angiogenesis in vivo
To test whether ALK5 inhibition was sufficient to restore
angiogenesis in vivo, we performed a VEGF-driven Matrigel
angiogenesis assays in non-irradiated mice and in locally pre-
irradiated mice treated systemically with either the ALK5 inhibitor
SB431542 or vehicle only. Treatment was started one day before
irradiation and was pursued throughout the duration of the
experiment. SB431542 treatment prevented the inhibition of
VEGF-induced angiogenesis observed in pre-irradiated mice while it
did not alter VEGF-induced angiogenesis in non-irradiated controls
(Figure 9). Therefore we conclude that ALK5 signaling plays a
dominant role in the suppression of angiogenesis induced by ionizing
radiation in vivo.
Discussion
Emerging evidence indicates that endothelial cells are sensitive
to ionizing radiations, and endothelial dysfunctions induced by
radiotherapy might be responsible for some of its wanted as well as
unwanted effects. To date, however, no comprehensive charac-
terization of such anti-angiogenic effect and its possible cellular
and molecular mechanisms, have been reported. In this work we
have investigated the effect of ionizing radiation on de novo
angiogenesis using in vivo, ex vivo and in vitro experimental models in
combination with genetic and pharmacological interventions.
Here we report that: i) High doses of ionizing radiation suppressed
angiogenesis in vivo, prevented endothelial cell re-entry into the cell
cycle, inhibited migration and sprouting in vitro without causing
increased apoptosis. ii) P53 and P21 were activated by radiation
but their absence or silencing did not prevent radiation-induced
inhibition of endothelial cell sprouting or proliferation. iii)
Ionizing radiation induced ALK5-dependent signaling in endo-
thelial cells and ALK5 inhibition rescued deficient endothelial cell
sprouting and migration but not proliferation in vitro, and restored
angiogenesis in irradiated mice in vivo.
A first important corollary of these observations is that ionizing
radiation suppresses sprouting angiogenesis by acting directly on
endothelial cells without the need for other cell types such as vessel
wall cells or stromal cells. This conclusion is based on the cell
autonomous inhibition of migration and sprouting in the spheroid
assay. The critical endothelial cell events contributing to
angiogenesis that are inhibited by radiation are migration and
sprouting. In contrast, radiation-induced impaired proliferation
and premature senescence seem not to be critical, at least within
the tested experimental conditions. Radiation-induced endothelial
cell senescence was reported earlier among irradiated (8 Gy)
proliferating cells that survived irradiation after most cells died by
apoptosis [32,33]. Our results are consistent with these reports by
showing that ionizing radiation kills proliferating endothelial cells
while it induces senescence in quiescent cells. Since replicative
senescent HUVEC also have reduced migratory capacities, one
may consider that endothelial cell senescence, regardless of its
cause, is associated with impaired migration. In contrast we could
not obtain in vivo or in vitro experimental evidence for increased
apoptosis of irradiated quiescent or confluent endothelial cells.
While this negative result does not formally exclude that radiation-
induced apoptosis may indeed occur, it nevertheless excludes
apoptosis as the main mechanism of radiation-induced inhibition
of de novo angiogenesis.
To unravel the molecular mechanisms possibly involved in
mediating these radiation effects, we initially focused on the P53-
P21 pathway for two reasons: first, this pathway is activated in
irradiated endothelial cells, as a consequence of DNA double
strand breaks and activation of DNA damage-sensing complexes
[34] and, second, P21 expression causes cell cycle arrest and
premature senescence, including in endothelial cells [35,36]. Using
aortic rings from mice deficient for p53 or p21 and silencing of P21
in HUVEC, however, we were unable to rescue proliferation
arrest and deficient sprouting, and we could only partially prevent
radiation-induced senescence and migration defects. Inhibition of
stromal P53 through retrovirus-mediated delivery of dominant
negative P53, was reported to enhance the anti-tumor angiogen-
esis effects of radiotherapy on tumoral vessels [37]. This, effect,
however, is likely due to the enhancement of the genotoxic effect of
Figure 3. Irradiation induces senescence of confluent endothelial cells. (a) Confluent HUVEC were irradiated with 15 Gy or not, and 4 days
later cultures were split at 1:3 dilutions and cultures photographed at 1, 3, and 5 days after splitting. Right panel gives the number of cells in non-
irradiated and irradiated cultures at the indicated times (n = 5). Bars = 50 mm. (b) Flow cytometry-based cell cycle analysis of confluent HUVEC
collected 4 days after radiation. Cells were stained with an anti-Ki67 antibody and 7-AAD dye. Bars show the relative percentage of HUVEC in the
different phases of the cell cycle (G0, G1 and G2/M1). (c) Non-irradiated and 15 Gy irradiated HUVEC were fixed 4 or 96 hours after irradiation and
stained to detect senescence-associated b-galactosidase activity at pH= 6. Pictures show stained (b-gal staining) and unstained cultures (phase).
Irradiated HUVEC acquired b-gal staining and a flattened, enlarged and granular cytoplasm. The bar graph gives the number of b-gal positive cells
normalized by total number of cells. (n = 5). *P,0.00001.
doi:10.1371/journal.pone.0011084.g003
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Figure 4. Irradiation inhibits endothelial sprouting from aortic rings. (a) C57/BL6 mice received 15 Gy whole body irradiation. Aorta were
explanted at day 5, sliced into rings and embedded in collagen I gels. The number of sprouts was quantified and images were taken at the indicated
days after embedding. Aortic rings obtained from non-irradiated mice were used as control. *P,0.01, **P,0.001. (b) C57/BL6 mice received 5 times
3 Gy whole body radiation every 2 days (total dose = 15 Gy). The aorta was explanted 5 days after the last dose, sliced into rings and embedded in
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radiotherapy on proliferating and retrovirally infected endothelial
cells, and is therefore likely to be distinct from the effect reported
here. The potential mechanism, by which P21 silencing partially
prevented radiation-induced senescence and migration defect, but
not sprouting or proliferation defects, is unclear at this point.
We found that radiation activates TGF-b type I receptor/ALK5
signaling and that inhibition of ALK5 kinase activity rescues
deficient migration and sprouting in vitro and angiogenesis in vivo.
These findings are consistent with and extend previously published
observations on the induction of TGF-b by radiation and on its
role in mediating radiation-induced biological effects [22,38]. In
the skin, TGF-b induction was reported as early as 6 hours after
single dose of c-irradiation [39,40]. TGF-b was shown to inhibit
cell proliferation through P21-depedent and independent mech-
anisms [41,42,43,44] and to decrease cell migration by, at least in
part, PAI-1 expression [44]. Further, constitutively active forms of
ALK1 and ALK5 inhibited growth factor-induced endothelial
sprouting from embryoid bodies [45]. In our model ALK5
inhibition, however, did not rescue the proliferation defect. We
have also tested the role of Notch signaling in the inhibition of
proliferation. Notch is activated by ionizing radiation [26] (and
our data) and was shown to inhibit angiogenesis [46] and to induce
endothelial cell proliferation arrest [47]. Notch inhibition, alone or
in combination with ALK5 inhibition, however did not rescue the
proliferation defect. In future experiments it will be interesting to
inhibit TGF-b using blocking antibodies [24] to see whether the
same rescue effect is observed.
The elusive nature of the mechanisms inhibiting proliferation
and causing senescence is likely to reflect the complexity and
redundancy of the mechanisms controlling such vital cellular
functions as well as the multiplicity of signaling events elicited by
ionizing radiations. Unraveling the mechanism of inhibited
proliferation will require significant further work and may profit
from a system biology approach [48].
The demonstration that inhibition of de novo angiogenesis is a
direct effect of high-doses ionizing radiations on endothelial cells
has two relevant implications to radiotherapy. On the one side it
suggests that the curative-intent and adjuvant effects of radiother-
apy may involve, at least in part, inhibition of tumor angiogenesis.
The introduction of anti-angiogenic drugs into clinical practice has
demonstrated that inhibition of tumor angiogenesis, mostly in
combination with chemotherapy, extends progression-free and
overall survival in several cancers [49]. Combination of anti-
angiogenic drugs with radiotherapy may elicit even greater anti-
tumor effects. At the same time, radiation-induced inhibition of de
novo angiogenesis might also explain why cancers recurring within
a previously irradiated field have a greater propensity to form
metastases and are associated with poor prognosis compared to
recurrences outside irradiated areas [50,51,52]. Others and we
have shown that tumors growing within a preirradiated area have
reduced angiogenesis and reduced growth, and are more hypoxic,
more invasive and more metastatic compared to tumors growing
in non-irradiated tissues [53,54]. In those experiments, however, it
was not clear whether inhibited angiogenesis was a primary effect
of radiation or was a consequence of reduced tumor growth. Our
findings support the first possibility thereby implicating inhibition
of angiogenesis in the tumor bed effect. Chronic hypoxia of tumors
growing within such an angiogenesis-deficient tissues will activate
pro-invasive programs [55] or select for resistant cells with invasive
characteristics [54]. This view is consistent with a recent report
demonstrating that inhibition of tumor angiogenesis by anti-
angiogenic drugs is associated with increased invasion and
metastasis formation in experimental tumor models [56]. Such a
mechanism, however, does not exclude that other ones might be
involved in promoting post-radiation tumor invasion. In fact,
TGF-b itself, a factor well-known to promote epithelial-mesen-
chymal transition [57], might also contribute to enhanced invasion
and metastasis of cancers growing in a irradiated tissue [58]. These
observations suggest the possibility of using ALK5 inhibitors
during radiotherapy to prevent radiation-induced inhibition of
angiogenesis and with it some of its unwanted effects. While this is
an attractive option, great caution should be considered at this
point since the TGF-b system has pleiotropic activities in normal
tissue homeostasis and other pathological conditions and its
collagen I gels. Aortic rings obtained from non-irradiated mice were used as positive controls. The number of sprouts was quantified and images were
taken at the indicated days. Bars = 500 mm. *P,0.0001. NIR: non-irradiated, IR: irradiated. (c) Aortas were explanted from wild type C57/BL6 mice,
sliced into rings, embedded in collagen I gels and 2 days later irradiated with 8 Gy. The number of sprouts was quantified immediately before (t = 0),
and at 1, 3, and 5 days after radiation. Bars = 500 mm. *P,0.01, **P,0.001. n.s, non significant. For each assay the number of sprouts was counted
manually each day under a dissection microscope. Bar graphs on the right represent the number of sprouts. White bars: sprouting from non-
irradiated mice or rings; Black bars, sprouting from irradiated mice or rings.
doi:10.1371/journal.pone.0011084.g004
Figure 5. Irradiation inhibits sprouting of isolated endothelial cells. HUVEC spheroids were embedded in collagen gels and exposed to 8 Gy
radiation. The cumulative sprout length was quantified from 10 randomly observed spheroids in each condition 24 hours later. There is a dose-
dependent decrease of sprouting in irradiated cultures. Bars = 100 mm. *P,0.01, **P,0.001. NIR: non-irradiated, IR: irradiated.
doi:10.1371/journal.pone.0011084.g005
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imbalance may lead to unwanted or unpredictable effects on its
own [59]. Inhibitors of ALK5 are in clinical development,
including as anti-cancer agents [60] and results generated by
these trials will be very informative on this matter.
This work has two intrinsic limitations. The first one is that,
with one exception, we used single, high doses of radiation (8, 15
and 20 Gy), depending on the assay used. In contrast, clinical
radiotherapy involves the repeated delivery of rather low doses of
radiation, i.e. 1.8–2.2 Gy (fractionated therapy). While single
high doses are often used in experimental models instead of
fractionated therapy, caution should nevertheless be taken when
translating results obtained with singles high doses into fraction-
ated regimens used in the clinic. In fact we have little knowledge
on how endothelial cells react to singles high doses of compared
to multiple low doses [61]. Considering the clinical relevance of
these effects, studies directly comparing the effects on tumor
angiogenesis of fractionated vs single high-dose treatments are
needed. The second limitation is that the effects on endothelial
cells and angiogenesis were studies in the absence of a tumor.
While this was done on purpose to selectively focus on direct
radiation effects on quiescent endothelial cells, it is plausible that
in the tumor microenvironment additional radiation-induced
effects might come into play and overlap with the events reported
here. A recent study demonstrated that tumor vessels re-growing
after radiotherapy do so by switching from sprouting to
intussusceptive angiogenesis, resulting in a 30% to 40% decrease
in the intratumoral microvascular density at tumor recovery [62].
This switch in the mechanism of angiogenesis might explain the
ability of tumors to growth in a pre-irradiated tissue in spite of
fully blocked sprouting angiogenesis. Alternatively, radiation
effects on bone marrow-derived cells may also contribute to the
suppressed angiogenesis in irradiated tumors. Decreased matrix
metalloproteinase-9 delivery by CD11b-positive bone marrow-
derived myelomonocytic cells was shown to be responsible for the
angiogenic blockade observed in irradiated tumors [63]. Fur-
thermore, radiation was reported to mobilize bone marow-
derived vascular progenitors [64] and CD11b+ cells which recruit
to irradiated sites to promote vessel formation though a
vasculogenic mechanism [65]. In future studies it will be
important to compare radiation effects on endothelial cells vs.
tumor-infiltrating bone marrow-derived cells in deficient angio-
genesis and vasculogenic rescue.
In conclusion, our work demonstrates that radiation inhibits
VEGF and FGF-2–induced angiogenesis through TGF-bRI/
ALK5 –dependent (i.e. impaired migration and sprouting) and
independent (i.e. cell cycle arrest and senescence) mechanisms.
Radiation-induced endothelial cell apoptosis, and the p53-P21
pathway are not critically involved in radiation-induced suppres-
sion of angiogenesis. These results represent an important progress
to the understanding of radiation-induced endothelial cell
dysfunctions leading to impaired angiogenesis. Further studies
are required to unravel additional mechanisms involved in these
effects and to assess the clinical impact of these observations.
Methods
Antibodies and reagents
Primary antibodies for staining were purchased from the
following companies; anti-CD31 (Pharmingen, San Diego, CA,
USA), anti-aSMA cy3-conjugated (Sigma, Buchs, Switzerland),
anti-phalloidin Alexa Fluor 568 conjugated (Molecular Probes,
Eugene, OR, USA), anti-Paxillin (Transduction laboratories,
Lexington, KY, USA), anti-phospho-H2AX (Upstate, Billerica,
MA, USA), anti-P21, anti-P53, anti-P16, anti-Smad 2/3 and anti-
phospho-Smad2 (Cell Signaling technology Inc. Danvers, MA,
USA). Collagen I was from Upstate (Billerica, MA, USA).
Recombinant human FGF-2 was from Peprotech EC Ltd
(London, UK). Mouse VEGF was purchased from R&D Systems
(Minneapolis, MN, USA). DAPI, Bovine serum albumin (BSA),
paraformaldehyde (PFA), gelatin, fibronectin and collagen were
purchased from Sigma Chemie (Buchs, Switzerland). Growth
factor reduced Matrigel Matrix (MG) was from Becton Dickinson
(Basel, Switzerland). TGF-b receptor I inhibitor: SB431542 was
purchased from Tocris (Bristol, UK). The c-secretase inhibitor
DAPT was purchased from Calbiochem (San Diego, CA).
Mice
C57/BL6 and Swiss nude mice were purchased from Harlan
Nederland, Madison, WI, USA. p53 -/- mice were provided by Dr.
Lawrence A. Donehower (Baylor College of Medicine, Houston,
Texas, USA) and p21-/- and p16Ink4A-/- mice were provided by
Dr. Friedrich Beermann (ISREC-EPFL, Lausanne, Switzerland).
All experiments involving mice were performed in accordance
with the guidelines of the Swiss Federal Veterinary Office (SFVO)
and were approved by the Veterinary Office of Cantonal Vaud
(Authorization number 1486.2).
Cell lines and cell culture
HUVECs were prepared as previously described [66], and were
cultured in 0.5% gelatin-coated dish in M199 medium (Invitrogen,
Basel, Switzerland) supplemented with 10% FCS, 12 mg/ml of
bovine brain extract (BBE: Clonetics, Walkersville, MD, USA),
10 ng/ml human recombinant EGF (Genzyme, Cambridge, MA,
USA), 25 U/ml heparin, 1 mg/ml hydrocortisone (Sigma Chemie,
Buchs, Switzerland) and 1% P/S. All cells were maintained in a
humidified incubator at 37uC with 5% CO2.
Irradiation
For in vivo irradiation experiments we used 6–10 weeks old C57/
BL6 and Swiss nude female mice (Harlan Nederland, Madison,
WI, USA). Before radiation, the mice were anesthetized with
intra-peritoneal injection of ketamin/xylazine mixture. Local
radiation was performed 7 days before Matrigel injection on the
back with a single dose of 20 Gy by using a X-ray unit (PHILIPS,
RT250, Germany), operated at 220 kV, 20 mA, with a 0.5 mm
Cu filtration. The mice were placed into a lead jig allowing
local irradiation sparing vital organs. The radiation field was
Figure 6. Irradiation impairs endothelial cell migration. (a) The effect of radiation on cell migration was examined by a scratch wound closure
assay in vitro. Confluent HUVEC were irradiated with 15 Gy, and 4 days later a scratch-wound was created. The micrographs represent the wound
immediately after the scratch (t = 0) and at 10 hours later. Bars = 30 mm (b) Wound closure was monitored by time-lapse microscopy and the distance
and speed of individual cells were calculated. Ionizing radiations inhibit HUVEC migration. *P,0.0001. (c) Non-irradiated and 15 Gy irradiated HUVEC
were tested for adhesion to collagen I and fibronectin on a short-term adhesion assay. *P,0.0001. Coll-I: collagen I, Fn: fibronectin. Irradiated cells
adhere more efficiently to both substrates. (d) Radiation effect on adhesion complexes and the cytoskeleton. Confluent HUVEC were irradiated with
15 Gy. Four, 24 hours and 4 days after radiation, a line-scratch wound was made on the cell monolayer, and 10 hours later, cultures were fixed and
stained by immunofluorescence with phalloidin (red) and anti-paxillin antibody (green) to reveal the actin cytoskeleton and focal adhesions. Pictures
of cells at the wound edge and at confluent region are shown. Migrating NIR cells at the wounding edge are polarized (L, leading edge; T, trailing
end), while non-migrating IR cells and cells in confluent regions are not polarized. Bars = 5 mm. NIR: non-irradiated, IR: irradiated conditions.
doi:10.1371/journal.pone.0011084.g006
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25625 mm2, and a dose rate of 0.6 Gy/min was used. For whole
body radiation, the mice were anesthetized as described above,
and placed on the flat table. A single X-ray dose of 15 Gy or
multiple doses of 3 Gy every 2 days until the same cumulated dose
was reached (fractionated dose) were given to the mice using the
same machine operated at 125 kV, 20 mA, with a Al filtration.
For in vitro radiation, a single dose of 8 Gy or 15 Gy was given
to HUVEC and aortic rings.
Matrigel plug angiogenesis assay
Matrigel plug angiogenesis assay was adapted from previously
described assay [67]. Briefly, 7 days after 20 Gy local radiation of
Swiss nude mice, two MG plug were (400 ml/plug) supplemented
with FGF-2 (500 ng/ml) and Heparin (3 U/ml, Sigma Chemie,
Buchs, Switzerland) and implanted within (dorsal) or outside
(ventral) the irradiation area. For VEGF-induced angiogenesis,
MG plugs was supplemented with mouse recombinant VEGF
(200 ng/ml) and Heparin (10 U/ml) and implanted in C57/BL6
mice. C57/BL6 mice were used since VEGF-induced MG plug
angiogenesis is more robust in these mice compared to Swiss nude
mice. Seven days after MG injection, the plugs were removed and
angiogenic responses were examined microscopically, biochemi-
cally and microscopically. Determination of hemoglobin content
was performed using the Drabkin’s reagent [68], or the
diaminofluorene (DAF) method [69] (Sigma Chemie, Buchs
Switzerland). Detection of CD31-positive endothelial cells was
performed by immunostaining. Inhibition of ALK5 signaling was
performed by the i.p. administration of SB431542 compound
(10 mg/kg/mouse) daily starting one day before irradiation until
the end of the experiment.
Mouse aortic ring assay
The protocol of mouse aortic ring assay was kindly provided by
Andrew Reynolds (Hodivala-Dilke’s laboratory, London, UK).
Eight weeks old adult C57/BL6 female mice were whole body
irradiated at 15 Gy, and 5 days later they were sacrificed. The
mice were dissected and the aorta was removed under sterile
conditions in a laminar-flow hood using binocular microscope
(Leica, MZ16, Heerbrugg, Switzerland). The aorta was cut in 1–
2 mm thick rings, and all the rings were cultured in serum-free
Optimem medium (Invitrogen, Basel, Switzerland) over night. The
following day, collagen gels were prepared by using a 1.2 mg/ml
collagen I solution (pH neutral) diluted in dH2O and mixed with
2xDMEM solution, and aliquoted into 50 ml/well in a 96 well
tissue culture plate. The rings were then placed in the collagen
solution at one ring per well. After 30 min polymerization of
collagen at 37uC with 5% CO2, 150 ml of DMEM supplemented
with 2.5% FCS and 30 ng/ml mouse recombinant VEGF were
added over the collagen gel, and the plate was maintained in the
incubator at 37uC and 5% CO2. The medium was refreshed each
2 days. ALK5 signaling was inhibited by adding SB431542 at
10 mM in the medium 2 days after embedding of rings in collagen
gels. Sprouting angiogenesis was quantified by counting the
number of branching sprouts. The sprouts were counted under the
microscope between day 4 and 7 after initiation of the cultures and
pictures were taken starting at the same time.
Endothelial cell spheroid sprouting assay
To form spheroids, 1.66105 HUVEC were mixed with 1.2%
methyl cellulose solution (Sigma, Buchs, Switzerland) and M119
complete medium. The cell suspension was distributed into 96-well
U-shape culture plate (Greiner bio-one, Frickenhausen, Germany)
and cultured overnight, following published protocols [16]. Next
day, the spheroids were harvested and mixed with Rat tail collagen
(pH neutral, final concentration at 2.4 mg/ml) diluted in dH2O,
2xDMEM, and 1.2% methyl cellulose solution, One ml of
spheroids-containing collagen solution was aliquoted into wells
in pre-warmed 24-well culture plates (Greiner bio-one) and the
collagen was let to polymerize for 30 minutes at 37uC. 100 ml
DMEM containing human VEGF (10 ng/ml final) and 10% FCS
were added over the polymerized collagen gel, and immediately
after the plate was irradiated with 15 Gy. Inhibition of ALK5 was
achieved by adding the SB431542 compounds to the spheroids-
containing gels at 10 mM final concentration. Twenty-four hours
after incubation, endothelial sprouting was measured from 10
individual spheroids per condition.
Cell survival and proliferation assay
Fully confluent HUVEC were exposed to 15 Gy radiation at
single dose. Four days after the exposure, the cells were split at 1:3
dilutions and further monitored for their growth for up to 5 days.
The cells were cultured under normal condition at 37uC with 5%
CO2. Non-irradiated HUVEC were used as control. SB431542
was added at 10 mM to the medium one day before the
irradiation, and the medium was changed every 2 days throughout
whole experimental period.
Wound migration assay
Confluent HUVEC were prepared in 35 mm dishes and
exposed to 15 Gy radiation at single dose. 4 days after radiation,
a wound line was created in each dish. Floating cells were washed
away with M199 medium. Cell migration was monitored for up to
20 hours at 6 minutes intervals by Time-lapse microscopy
(Axiovert100 equipped with a heated CO2 chamber, Carl Zeiss,
Feldbach, Switzerland). Images were analyzed with MetaMorph
and ImageJ softwares. The speed and distance of migration of 10
single cells from one field was calculated for each condition with
MTrackJ plugin in ImageJ. Three fields were chosen from each
condition and data were analyzed by Student’s t-test. The
inhibition of ALK5 was performed by adding SB431542 at
10 mM in the medium 1 day before the radiation and the inhibitor
containing medium was refreshed every 2 days.
Cell adhesion assay
NUNC Maxisorp II (NUNC, Roskilde, Denmark) ELISA plates
were coated with fibronectin (3 mg/ml) or collagen (1 mg/ml) over
night at 4uC and blocked with 1% BSA for 1 hours at 37uC. Assays
Figure 7. Role of radiation-induced activation of the P53-P21 pathway in senescence andmigration. (a) Confluent HUVEC were irradiated at
15 Gy or not and analyzed for DNA double strand breaks by immunofluorescence staining using anti-P-H2AX mAb (green) at indicated time points. DAPI
staining (blue) was used to detect nuclear DNA. Double strand breaks were repaired within 24 hours. (n= 5). Bars = 5 mm. (b) The expression level of three
senescence-associated proteins, P16, P21 and P53, was analyzed by Western blotting before (0 hours) and after radiation at indicated time points. Actin
was used as loading control. P53 levels are increased 6 hours after radiation, followed by an increase in P21 level. (n= 3). (c) HUVEC were transduced with
lentiviruses expressing four different P21shRNA (1–4), no insert (empty vector) and non-silencing shRNA. HUVEC infected with P21shRNA # 3 were used
for the functional experiments. (d) Senescence b-gal staining on control and P21 silenced HUVEC at 4 hours and 4 days after irradiation. (n= 6). (e)
Migration ability of P21 silenced HUVEC was monitored by wound scratching assay. There was partial rescue of migration defect and decrease in number
of senescence positive cells in P21 silenced HUVEC. (n= 3) *P,0.001. NIR: non-irradiated, IR: irradiated, NS: non-silencing HUVEC.
doi:10.1371/journal.pone.0011084.g007
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were done as previously described [66]. Briefly, Confluent
irradiated HUVEC were maintained for 4 days after 15 Gy
radiation, single dose. HUVEC were collected by trypsin digestion
and seeded in serum-free M199 medium at 26104 cells/well. After
the incubation at 37uC for 1 hour, the wells were gently washed
with warm PBS and fixed for 30 minutes at RT with 2%
paraformaldehyde (Fluka Chemie, Buchs, Switzerland). Cells were
stained with 0.5% crystal violet, and absorbance of each well was
read at 620 nm in a plate reader (Packard Spectra Count, Meriden,
CT, USA). Results are normalized by BSA coated control wells and
expressed as mean values of triplicate determinations 6 s.d.
Senescence-associated b-galactosidase assay
The senescence-associated b-galactosidase (b-gal) assay was
performed using a senescence b-galactosidase staining kit (Cell
signaling, Danvers, MA, USA) according to manufacturer’s
instructions. Confluent HUVEC were exposed to 15 Gy radiation.
To generate aged senescence HUVEC, cultures were passaged
for over 20 times at 1:3 dilutions (approx 60 divisions). b-
galactosidase-positive cells were counted under microscope
(AXIOVERT 40CFL: Carl Zeiss, Feldbach, Switzerland) and
normalized by the total number of cells. Values represent means6
s.d.
Figure 8. Radiation activates the TGF-bRI/ALK5 pathway and ALK5 inhibition prevents radiation-induced suppression of migration
and sprouting. (a) Increased Smad2 phosphorylation in irradiated cultured HUVEC and mouse skin (15 Gy and 20 Gy respectively) demonstrated by
Western blotting analysis. Induction of p-Smad2 was biphasic with early peaks at 2–6 hours and late peaks at 24–96 hours. (n = 3). (b) Radiation
induces the TGF-b pathway target PAI-1 gene in HUVEC. HUVEC were treated with the ALK5 inhibitor SB431542 at 10 mM one day before radiation.
RNA was extracted before and 2 hours after irradiation and PAI-1 mRNA quantified by real time RT-PCR. (c) The ALK5 inhibitor SB431542 (SB) rescued
the migration defects caused by radiation. Left panel: migration speed; right panel: migration distance. (n = 10) *P,0.001. (d) The ALK5 inhibitor
SB431542 (SB) rescued the sprouting defects caused by radiation. The SB compound was added in the medium during the whole mouse aortic ring
assay. Level of endothelial cell sprouting in the presence of SB reached to levels observed in non-irradiated/non-treated rings (n = 9) *P,0.05. (e) The
ALK5 inhibitor SB431542 (SB) rescued the radiation-induced sprouting defects in HUVEC spheroid assay. SB compound was added to spheroid-
containing collagen gel at 10 mM and the spheroids were exposed to 15 Gy radiation. Endothelial sprouting was quantified 24 hours after incubation.
(n = 10) *P,0.05, **P,0.001. NIR: non-irradiated, IR: irradiated, SB: SB431542.
doi:10.1371/journal.pone.0011084.g008
Figure 9. The ALK5 inhibitor SB431542 prevents radiation-induced inhibition of angiogenesis in the Matrigel plug assay. VEGF-
induced angiogenesis was performed in non-irradiated or irradiated (20 Gy) C57/BL6 mice, which were treated with SB431542 (SB) compound, or
vehicle only, daily from one day before irradiation until the end of the experiment. One week after Matrigel implantation, angiogenesis was
quantified by measuring haemoglobin content. Representative images of recovered plugs and quantification of haemoglobin content are shown.
(n = 7). Bars = 0.5 cm. *P,0.005. n.s., non significant. NIR: non-irradiated, IR: irradiated: SB: SB431542.
doi:10.1371/journal.pone.0011084.g009
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Immunostainings
After radiation, mouse skin biopsies were taken at the indicated
time points and frozen in OCT compound at 280uC. Explanted
Matrigel plugs were frozen the same way. Eight mm thick sections
were fixed in cold methanol for 10 minutes at 4uC. For CD31
immunohistochemical staining, sections were quenched in 0.3%
H2O2 in water for 10 minutes. Thereafter, sections were blocked
with 1.5% goat serum in PBS for 1 hour at room temperature
(RT), and incubated with primary antibodies in the same buffer for
1 hour at RT or over night at 4uC. After washing, sections were
incubated with the corresponding secondary antibodies labeled
with either AlexaFluor488 or AlexaFluor546 (Molecular Probes,
Eugene, OR, USA) for 1 hour at RT. Cell nuclei were
counterstained with 20 ng/ml DAPI for 5 minutes at RT. For
HUVEC staining, control or irradiated cultures were fixed with
2% PFA for 20 minutes at RT. Cells were permeabilized for 20
minutes at RT in 0.2% Triton X-100 in PBS, and then stained as
above. First antibodies were used at following concentrations: anti-
CD31 (1:50), anti-paxillin (1:50), anti-p-H2AX (1:100). Actin was
stained with Alexa Fluor 568-conjugated Phalloidin (1:100
dilution), for 30 minutes at RT. TUNEL staining was performed
using the In Situ Cell Death Detection Kit, Fluorescein (Roche,
Basel, Switzerland) and following manufacturer’s instructions.
Flow cytometry
Confluent HUVEC were exposed to 15 Gy radiation and
collected at 0, 6, 12, 24, and 96 hours after irradiation. The assay
was performed according to manufacturer’s instructions. Apopto-
sis was detected using the Annexin V-7AAD Apoptosis Detection
Kit I (BD Biosciences, Allschwil, Switzerland) following manufac-
turer’s instructions. For cell cycle analysis, confluent HUVEC
were irradiated at 15 Gy, and 24 hours and 4 days later cells were
harvested and fixed for 30 minutes at 4uC in FACS buffer
containing 0.4% PFA. 1 ml FACS buffer containing 0.2% Triton-
X-100 was added to the same tube and incubated over night at
4uC for permeabilization. Cells were stained with PE-Ki67 (BD
Pharmingen, San Diego, CA, USA) for 1 hour at 4uC. After
washing, 7-AAD (BD Pharmingen, San Diego, CA, USA) was
added and cells incubated for 15 minutes at RT in the dark. Cells
were analyzed using a FACScan II equipped for three color flow
cytometry, and data were analyzed using CellQuest software
(Becton Dickinson Biosciences, Mountain View, CA, USA).
SDS-PAGE and Western blotting
Cells were lysed in ice cold modified RIPA buffer, sonicated and
centrifuged at 13,000 rpm for 15 minutes at 4uC to remove debris.
Proteins were resolved by SDS-PAGE and blotted onto Immobi-
lon-P membranes (Milipore, Volketswil, Switzerland). Membranes
were sequentially blocked in 5% dry milk for 1 hour at RT and
then incubated with anti-p53, P21 and P16 antibodies at 1:2000
dilution overnight at 4uC for primary antibody reaction. An HRP-
labeled secondary antibody (DAKO, Zug, Switzerland) was used
at 1:2000 dilutions for 1 hour at RT. The ECL system was used
for detection (Amersham-Pharmacia Biotech, Du¨bendorf, Swit-
zerland). Unless otherwise indicated, experiments were carried out
a minimum of three times to yield similar results. Representative
experiments are shown.
Real time RT-PCR
Gene expression was quantified by real time PCR on an ABI
StepOne Plus machine (Applied Biosytems). Real-time PCR was
carried out using SYBRGreenmaster mix. The primer and Applied
Biosystems gene expression essay used are given below. The
comparative Ct method was used to calculate the difference of gene
expression between samples. The 2-[DELTA][DELTA]Ct calcu-
lation is a convenient alternative method to the relative Standard
Curve Method to derive accurate quantitative information from
real time PCR assays [70]. Quantity of cDNA was normalized using
the housekeeping gene GAPDH. The following primers were used:
human GAPDH forward (F): 59-ATCCCATCACCATCTTC-
CAG-39; human GAPDH reverse (R): 59- CGAAATCCCAAAC-
TCCGATAGTC-39; human PAI-1 F: 59-CATCCCCCATCC-
TACGTGG-39; human PAI-1 R: 59-CCCCATAGGGTGAGAA-
AACCA-39; human TGF-b1 forward (F): GCAACAATTCC-
TGGCGATAC; human TGF-b1 reverse (R): GAACCCGTT-
GATGTCCACTT; human TGF-bRII forward (F): TTCAAGT-
GACAGGCATCAGC; human TGF-bRII reverse (R): GGTTG-
ATGTTGTTGGCACAC
Gene silencing
For P21 silencing in HUVEC, four different clones of p21
shRNA lentivirus particles were purchased from OpenBiosystemes
(RHS4531, NM_078467: Huntsville, USA). HUVEC were
transduced with each one of the lentivirus particles (MOI= 8)
following the supplied protocol. Forty-eight hours later, trans-
duced cells were selected by culturing them for 3 days in complete
medium supplemented with 3 mg/ml puromycine followed by
expansion in medium alone. Suppressed P21 expression was
demonstrated by Western blotting. p21shRNA3 gave the best
silencing efficiency and was used in functional experiments.
Statistical Analysis
Data were analyzed by Student’s t-test for both in vitro and in vivo
experiments using the statistical package in MS Excel Version
11.5.5 for Mac (Microsoft Corporation, Redmond, OR). P values,
0.05 were considered significant. Results are expressed as mean 6
s.d. depicted by error bars (95% confidence interval).
Supporting Information
Figure S1 Ionizing radiation kills proliferating but not quiescent
HUVEC in vitro. (a) Confluent HUVEC were exposed to 15 Gy
(IR) X-ray radiation and monitored for changes in morphology
and survival before irradiation (0 hours) and at 24 hours and 4
days after irradiation, and compared to non-irradiated (NIR)
HUVEC. No cell loss and no detectable morphological or density
differences between IR and NIR HUVEC were observed.
Bars = 30 mm. (b) Sub-confluent (50%) HUVEC were irradiated
at 15 Gy (IR) and observed before and at 24 hours and 4 days
after irradiation and compared to non-irradiated (NIR) HUVEC.
Irradiated sub-confluent HUVEC massively died within 4 days
after irradiation, whereas non-irradiated cultures proliferated and
reached confluence. Bars = 30 mm.
Found at: doi:10.1371/journal.pone.0011084.s001 (3.25 MB TIF)
Figure S2 Replicative senescence of HUVEC is associated with
reduced migration. Replicative senescent HUVEC cells (RS) were
prepared by passaging cultures 20 times. The migration capacities
of non-irradiated HUVEC (NIR), replicative senescent HUVEC
and 15 Gy irradiated HUVEC (IR) were tested by the scratch
wound closure assay in which individual cells were monitored for
their migration speed. RS and IR HUVEC have reduced
migratory capacities.
Found at: doi:10.1371/journal.pone.0011084.s002 (3.25 MB TIF)
Figure S3 P53 or P21 deficiency does not prevent radiation-
induced proliferation arrest or sprouting (a) Confluent, non-
silenced (NS) and P21 silenced (P21shRNA3) HUVEC were
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irradiated at 15 Gy, and 4 days later they were split at 1:3 dilutions
to monitor their proliferation ability. P21 silencing dramatically
increased proliferation of non-irradiated HUVEC, but did not
rescue the proliferation defect in irradiated HUVEC. (b) Mouse
aortic ring assay from p21 null mice. The mice were exposed to
15 Gy whole body irradiation 5 days before the aorta was
dissected. p21 deficiency did not rescue the radiation-induced
inhibition of sprouting. *P,0.05, **P,0.01. (c) Mouse aortic ring
assay from p53 null mice. Wild type and p53 null mice were
exposed to 15 Gy whole body radiation 5 days before aorta
dissection. Absence of p53 did not rescue the inhibition of
sprouting by ionizing radiation. *P,0.01. NIR: non-irradiated,
IR: irradiated, NS: non-silencing.
Found at: doi:10.1371/journal.pone.0011084.s003 (3.25 MB TIF)
Figure S4 Radiation induces TGFbRII, but not TGFb, mRNA
expression in endothelial cells. (a) Endothelial cells were irradiated
with 15 Gy single dose, total RNA was extracted before (t = 0) and
at 6, 12, 24 and 96 hours after irradiation and TGFb mRNA
quantified by real time RT-PCR. (b) Endothelial cells were
irradiated with 15 Gy single dose, total RNA was extracted before
(t = 0) and at 2, 6, 12, 24 and 96 hours after irradiation and
TGFbRII mRNA quantified by real time RT-PCR. NIR: non-
irradiated, IR: irradiated. Representatives of duplicate experi-
ments are shown.
Found at: doi:10.1371/journal.pone.0011084.s004 (3.25 MB TIF)
Figure S5 Inhibition of ALK5, alone of in combination with
Notch inhibition, does not rescue radiation-induced proliferation
arrest. (a) HUVEC were treated with the ALK5 inhibitor
SB431542 at 10 mM, 24 hours before radiation. Four days after
radiation, the cells were split at 1:3 dilutions to monitor further
proliferation. In the presence of SB431542 non-irradiated
HUVEC significantly increased their proliferation, however there
was no rescue of proliferation defect of irradiated cells. *P,0.001.
(b) HUVEC were treated with the ALK5 inhibitor SB431542 and
the c-secretase inhibitor GSI at 10 mM one day before radiation.
RNA was extracted from non-irradiated HUVEC and from
HUVEC 2 hours after irradiation, and Hey1 mRNA expression
analyzed by real time RT-PCR. Radiation induced Hey-1, which
was blocked by GSI or GSI+SB, but was enhanced by SB alone.
(c) Effect of GSI, SB431542, singly and in combination, on
inhibition of HUVEC proliferation following radiation. Inhibitors
were added in the medium 1 day before radiation. HUVEC were
exposed to 15 Gy radiation and cultured for 4 days. Cells were
split at 1:3 dilutions and the cell proliferation was monitored at 1,
2, 3 and 4 days after splitting. There was no rescue of radiation-
induced proliferation defects by blocking Notch alone or in
combination with ALK5 inhibition. NIR: non-irradiated, IR:
irradiated, SB: SB431542, GSI, c-secretase inhibitor.
Found at: doi:10.1371/journal.pone.0011084.s005 (3.25 MB TIF)
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